• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Zai
Biotech

With global goals, Zai Lab offers China reality check

With their first-hand experience of Chinese biopharma, Zai Lab leaders don't think the nation's rise poses an imminent threat to U.S. dominance.
Darren Incorvaia Apr 20, 2026 2:12pm
Eli Lilly Lilly

Lilly bags another in vivo CAR-T biotech via $7B Kelonia deal

Apr 20, 2026 10:15am
3 bioprocessing trendsand the critical enabler thats quietly driving them

3 bioprocessing trends—and the critical enabler that’s quietly driving them

Brought to you by Savillex
FDA

AACR: Pazdur bemoans state of FDA, warns of political influence

Apr 18, 2026 4:00am
Yu Lu-Fierce Biotechjpg

How WuXi AppTec’s Integrated Platform Is Helping Therapies Move Faster from Discovery to Patients

Brought to you by WuXi AppTec
Odyssey boat greece

Odyssey charts new voyage to Nasdaq after false start last year

Apr 20, 2026 7:19am
More News

Shedding 60% of workforce, Replimune vows to continue operations

Apr 21, 2026 2:15am

Biogen inks $850M deal with TJ for China rights antibody

Apr 20, 2026 10:26am

Novo Nordisk readies SCD drug for approval push after ph. 3 win

Apr 20, 2026 8:33am

AstraZeneca’s faith in IL-33 blocker pays off with new ph. 3 win

Apr 20, 2026 7:22am
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings